An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)

Mise à jour : Il y a 4 ans
Référence : NCT00796120

Femme et Homme

Extrait

The purpose of this study is to evaluate the efficacy and safety of trabectedin compared to standard doxorubicin in participants with advanced translocation-related sarcomas (cancer of connective tissue cells) (TRS).


Critère d'inclusion

  • Sarcoma


Liens